Gevorg Tamamyan: The Day We Decided War Will No Longer Mean the End of Cancer Care
Highlights From How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit
Yvonne Awards 2026
OncoDaily Brings Sarcoma Experts Together at ASCO 2026
King Hussein Cancer Research Award: Advancing Cancer Research Across the Arab World 2026
Grand Rounds by OncoDaily: AI in Oncology Edition
Dario Trapani: Launching WHO Academy Webinar Series on National Cancer Control Planning
Helena Kremer: Brazilian Government Announces R$1.1 Billion Oncology Complex Integrated With INCA In Rio
NCCN will host a specialized tumor board session titled "Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma" on April 30, 2026, from 3:00 PM to 4:00 PM EDT. As the treatment paradigm for advanced classic Hodgkin lymphoma (cHL) shifts toward frontline antibody-drug conjugates and immune checkpoint inhibitors, clinicians must pivot from […]
The Lung Cancer Europe Conference 2026 is a dedicated advocacy and educational summit scheduled for April 22–24, 2026, in Vienna, Austria. This biennial event serves as a critical platform for LuCE member organizations, patients, caregivers, and healthcare professionals to align on European advocacy priorities. The technical program emphasizes practical exchange and peer-to-peer learning, focusing on […]
On April 22, 2026, NCCN will host a specialized clinical program titled "Optimizing Patient Outcomes - In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric Acute Lymphoblastic Leukemia." While pediatric ALL survival rates have improved significantly over decades, the integration of blinatumomab into upfront therapy for newly diagnosed B-cell ALL […]
The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24, 2026, in Athens, Greece. Under the leadership of Co-Chairs Helena Linardou, Giannis Mountzios, and Solange Peters, this course is designed to provide oncology professionals with a comprehensive update on the rapidly evolving […]
The webinar titled "Escalation or de-escalation? Strategies in HER2+ breast cancer treatment" is scheduled to take place on April 23, 2026, at 18:00 CEST. Organized by OncoCorner and Sharing Progress in Cancer Care (SPCC), this educational session focuses on optimizing neo/adjuvant treatment strategies for HER2-positive breast cancer. The discussion, featuring experts Roisin Connolly and Adrienne […]
The OncoDaily Multiple Myeloma Congress 2026 is scheduled for April 23, 2026, as a virtual global congress streaming live on YouTube and X. This event addresses a global burden of approximately 188,000 new annual diagnoses and 120,000 deaths, representing 0.9% of all newly diagnosed cancers and 1.2% of cancer-related deaths worldwide. In the United States […]
The "Oncology 101: An In-Depth Hematology and Oncology Review for Advanced Practice Providers" is a two-and-a-half-day virtual continuing education conference, presented by Horizon CME in partnership with APAO, scheduled for April 23–25, 2026. The program is designed to provide new or transitioning Advanced Practice Providers (APPs), nurses, and pharmacists in oncology with a crucial foundational […]
The Canadian Association of Pharmacy in Oncology (CAPhO) Conference 2026 will be held from April 23–26, 2026, at TCU Place in Saskatoon, Saskatchewan. Centered on the theme "Expanding Horizons in the Land of Living Skies," this premier event explores the future of oncology pharmacy through the lenses of precision medicine, technological innovation, and an evolving […]
The Advocates Webinar: External Control Arms in Oncology Drug Development, a free virtual event hosted by Friends of Cancer Research, is scheduled for Tuesday, April 23, 2026, from 1:00 PM to 2:00 PM ET. This webinar is designed to build on the earlier public meeting by focusing on what External Control Arms (ECAs) - which […]
NCCN will host a virtual master class titled "Precision in Practice: A Master Class on PARPi Combinations, Testing Strategies, and Toxicity Management in Metastatic Prostate Cancer" on Thursday, April 23, 2026, from 6:00 PM to 7:30 PM ET. Featuring a distinguished panel of experts, this session is designed to help community oncologists, urologists, and the […]
The APPOS Cincinnati 2026 (Advanced Practice Providers Oncology Summit) is a two-day continuing education conference tailored for advanced practice providers (APPs), including NPs, PAs, pharmacists, and nurses, who are part of the multidisciplinary oncology team. The summit is scheduled for April 24–25, 2026, and will be held at The Westin Cincinnati Hotel in Cincinnati, Ohio. […]
The ALRCaN Global webinar, “Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL,” is set for Friday, April 24, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Hisato Segoe, this session examines specialized clinical approaches for high-risk pediatric leukemia subtypes. Organized by the Acute […]
The 2026 IOTOX Symposium: Delivering What Matters - Patient-Centered through IOTOX Translational Science, organized by The University of Texas MD Anderson Cancer Center, is a hybrid educational event scheduled from Friday, April 24, to Saturday, April 25, 2026. This symposium is dedicated to bridging the gap between translational science and clinical practice, offering healthcare professionals […]
Harvesting Knowledge: A Summit on Multiple Myeloma is a specialized, one-day clinical program taking place on April 25, 2026, in Napa, California. Organized by Bio Ascend, this summit is designed to equip hematologists, oncologists, and nursing professionals with evidence-based strategies for managing multiple myeloma throughout the entire patient journey. The hybrid event features "State of […]
The European Conference on Interventional Oncology (ECIO) 2026 is the leading multidisciplinary platform for minimally invasive cancer care. Scheduled for April 26–30, 2026, the event will take place at the Congress Center Basel in Basel, Switzerland. Organized by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), the conference highlights interventional oncology (IO) as the […]
Celebrating its 20th landmark edition, the 20th International p53 Workshop arrives in Toronto from April 27 to May 1, 2026, to explore the frontier of the most frequently mutated gene in human cancer. Co-organized by Canada’s leading research powerhouses—University Health Network (UHN), the Lunenfeld-Tanenbaum Research Institute, and SickKids—this globally recognized summit gathers the world’s elite […]
